Publications by authors named "Lize Li"

Claim this Profile
P
Pharmacokinetics, Pharmacodynamics, and Safety of ET-26 in Subjects with Mild to Moderate Renal Impairment.
Fan Yang, Chao-Zhuang Shen, Pan-Pan Ye, Wen-Shuo Lv, Li-Ze Li

Drugs R D· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methoxyethyl Etomidate Hydrochloride (ET-26): A Phase I Clinical Trial Assessing Drug-Drug Interactions in Healthy Subjects.
Fan Yang, Pan-Pan Ye, Wen-Shuo Lv, Li-Ze Li, Bao-Zhong Zhao, Lin-Lin Song

J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of the pharmacokinetics, efficacy and safety of ET-26 in elderly and non-elderly subjects: the results of a phase I clinical trial.
Fan Yang, Jing Sun, Pan-Pan Ye, Wen-Shuo Lv, Li-Ze Li

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
InAlAs digital alloy avalanche photodiode with partially depleted absorber.
Wenyang Wang, Jinshan Yao, Lize Li, Luyu Wang, Tianyu Long

Opt Lett· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, mass balance, and metabolism of [C]FCN-437c, a selective and potent CDK4/6 inhibitor in humans.
Lei Gao, Sheng Ma, Shu Yan, Hua Zhang, Ling Tian, Lize Li, Liyan Miao

Cancer Chemother Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics and Concentration-QTc analysis of a new etomidate analog ET-26-HCl: a phase I trial in healthy Chinese subjects.
Kun He, Wenyu Zhang, Xiangran Kong, Lize Li, Lei Diao

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 single-centre placebo- and etomidate-controlled study in healthy volunteers to assess safety, tolerability, clinical effects, and pharmacokinetics of intravenous methoxyethyl etomidate hydrochloride (ET-26).
Qinqin Yin, Yang Yang, Jin Liu, Lize Li, Xiaoran Yang

Br J Anaesth· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No QTc prolongation with CDK 4/6 inhibitor FCN-437c: results of a concentration-QTc analysis from a dedicated study in adult healthy subjects.
Lin Zhao, Yi Sun, Xiaoran Yang, Ling Tian, Lize Li, Haiyan Li

Front Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis